findmyKOL

Brahmajee Nallamothu, MD

Enriched profile

Professor of Internal Medicine (Stevo Julius Research Professor of Cardiovascular Medicine) · University of Michigan Medical School

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Ann Arbor, MI · Midwest · United StatesSpecialtyCardiovascular DiseaseFocusCoronary Interventions and Diagnostics+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceNone verifiedPayments2024–2024NIH funding2005–2025

Brahmajee Nallamothu is Professor of Internal Medicine (Stevo Julius Research Professor of Cardiovascular Medicine) at University of Michigan Medical School. OpenAlex indexes 774 publications with 40,575 citations (h-index 95); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.

Data verified 12 Oct 2026

Overview

Updated 15 Oct 2026

Brahmajee Nallamothu, MD, is Professor of Internal Medicine (Stevo Julius Research Professor of Cardiovascular Medicine) at University of Michigan Medical School. The public record shows 774 publications with 40,575 citations (h-index 95), centered on Coronary Interventions and Diagnostics, Acute Myocardial Infarction Research, Cardiac Arrest and Resuscitation. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 2 companies, 8 NIH-funded awards (2005–2025).

  • Most recent indexed publication: 2026 · JMIR mHealth and uHealth
  • Top research focus: Coronary Interventions and Diagnostics
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 2 companies

Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Cardiovascular Diseases2 trialsVascular Diseases2 trialsHypertension2 trialsCoronary Artery Disease / ACS1 trialHeart Failure1 trialCoronary Artery Disease1 trialMyocardial Infarction1 trialHeart Valve Diseases1 trialAngina, Stable1 trialHeart Failure, Systolic1 trialInfarction1 trial

Research focus

OpenAlex concept fingerprint
Coronary Interventions and DiagnosticsAcute Myocardial Infarction ResearchCardiac Arrest and ResuscitationPalliative Care and End-of-Life IssuesCardiac Imaging and Diagnostics

Drugs & molecules

across trials, industry payments and publications
Leqviogeneric · InclisiranClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
University of MichiganClinical trials4Industry payments—Boston Scientific CorporationClinical trials—Industry payments1Novartis Pharmaceuticals CorporationClinical trials—Industry payments1University of California, San FranciscoClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
774publications

Distinct works indexed by OpenAlex, matched via ORCID; 43 in PubMed.

40,575citations

Total citations across indexed works.

95h-index

Hirsch index (OpenAlex). i10-index 349.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
2companies · 2024–2024

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
8NIH grants · 2005–2025

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 15 Oct 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 15 Oct 2026

2 companies reported payments to CMS in program years 2024–2024. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    83.8%
    Statin24.3%
    Atorvastatin Calcium100%
    Part D<11 patients
    Beta blocker20.7%
    Metoprolol Succinate100%
    Part D<11 patients

    + 3 more classes in this area

  • Blood & clotting

    16.2%
    P2Y12 inhibitor16.2%
    Clopidogrel100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 15 Oct 2026

8 NIH research awards on record, funded 2005–2025 per NIH RePORTER. The latest:

Publications

Updated 15 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 15 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Paul S. Chan111Harlan M. Krumholz101John A. Spertus60Jessica R. Golbus44Jeptha P. Curtis39Eric Bates37Steven M. Bradley34Saket R. Girotra34Henry H. Ting32Hitinder Singh Gurm31Sanjay K. Saint30Theodore John Iwashyna30Jessica L. Lehrich28Frederick A. Masoudi28Sunil V. Rao25John S. Rumsfeld25P. Michael Ho23Michael P. Dorsch22John M. Hollingsworth22Neil S. Kamdar20Elizabeth H. Bradley20Brad Trumpower19Robert W. Neumar19Thomas Felix Lüscher19Reza Fazel18Joseph S. Ross18Andrew M. Ryan18Joseph A. Hill18Yongfei Wang18Thomas T. Tsai18Kayvan Najarian17Kenneth M. Langa17Jersey Chen17Steven L. Kronick16Evan Luff16Akbar K. Waljee16Robert J. Gropler15Debabrata Mukherjee15Sanjeev V. Saksena15Christiaan J. Vrints15

Background & recognition

Updated 15 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Wayne State University

    1995
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →uofmhealth.org ↗
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →michiganmedicine.org ↗

Editorial & leadership roles

journal and society appointments
  • Editor-in-Chief

    Circulation: Cardiovascular Quality & Outcomes

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →annarbor.hsrd.research.va.gov ↗
  • Co-Director

    University of Michigan Precision Health Initiative

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →annarbor.hsrd.research.va.gov ↗

Secondary affiliations

appointments beyond the home institution
  • Staff Physician

    VA Ann Arbor Healthcare System

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →annarbor.hsrd.research.va.gov ↗
  • Research Investigator

    Center for Clinical Management Research, VA Ann Arbor Healthcare System

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →annarbor.hsrd.research.va.gov ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.